Spatial OMICS Market by Technology, Sample Type, Product, Workflow, End-use

List of Tables

[188 Pages Report] The Spatial OMICS Market size was estimated at USD 521.18 million in 2023 and expected to reach USD 586.66 million in 2024, at a CAGR 13.14% to reach USD 1,237.48 million by 2030.

Spatial omics encompasses advanced techniques and technologies for analyzing the spatial organization of biological molecules within cells, tissues, and organisms. This sector serves various industries, including pharmaceuticals, biotechnology, academic research, and diagnostics. Factors such as the rising prevalence of complex diseases like cancer, along with the advancements in next-generation sequencing (NGS) and government funding for life science research initiatives, have increased the application areas of spatial omics. However, high costs associated with implementing advanced imaging tools, along with data standardization and interoperability concerns, may impede market growth. However, booming technologies such as artificial intelligence (AI) and machine learning (ML) hold the potential to revolutionize data analysis in spatial omics studies. Furthermore, the development of integrated multi-omics platforms that combine transcriptomics, proteomics, metabolomics, and genomics, leveraging cloud computing technology, is expected to provide growth prospects for the market.

KEY MARKET STATISTICS
Base Year [2023]	USD 521.18 million
Estimated Year [2024]	USD 586.66 million
Forecast Year [2030]	USD 1,237.48 million
CAGR (%)	13.14%

Product: Penetration of mass spectrometry for spatial distribution of different molecules from tissue

Consumables include vital components such as reagents, probes, antibodies, and buffers for sample preparation, imaging, and data analysis. Researchers' preferences for consumables depend on factors such as sample type, target molecule, sensitivity levels, throughput needs, and budget constraints. Instruments are essential tools that generate high-quality data at various resolutions in spatial OMICS experiments. Key instruments encompass microscopes, slide scanners, mass spectrometry instruments, and next-generation sequencing platforms. Mass spectrometry imaging analyzes the spatial distribution of the number of molecules directly from tissue sections, usually placed on conductive glass slides to create conductivity on the sample surface. Software is vital for analyzing and interpreting spatial OMICS data through image segmentation tools. User preferences are determined by factors such as hardware compatibility, ease of use, integration with existing data analysis pipelines or LIMS systems, scalability, and customization options.

End-use: Significant application of spatial OMICS technologies by Academic & translational research institutes for cellular mechanisms studies

Academic & translational research institutes adopt spatial OMICS technologies to advance their research capabilities. Spatial OMICS tools allow academic & translational research institutes to have a better understanding of cellular mechanisms, disease progression, biomarker identification, and contribute towards the development of novel therapeutic interventions. Pharmaceutical & biotechnology companies are utilizing the Spatial OMICS technologies for prioritize target validation, biomarker identification, and streamlining drug discovery processes.

Regional Insights

The global spatial OMICS market is experiencing significant growth across the Americas region owing to significant investment led in research and development across regions such as the United States & Canada, supported by the presence of biotechnology & research companies along with academic institutions. In Europe, countries like Sweden and Germany lead investments in spatial OMICS technologies through EU-funded projects like Horizon 2020. Research institutes such as The European Bioinformatics Institute(EMBL) and Wellcome Sanger Institute contribute significantly to advancing this field. Increasing focus on precision medicine and genomic research in the Middle East region opens up opportunities for adopting spatial OMIC technologies in clinical decision-making. Moreover, the Asia Pacific region holds the growth potential for the spatial OMICS, considering the growing biotechnology sectors and increased government funding for scientific research across major economies such as China & India. India is gradually adopting spatial OMIC technology through substantial investments by its Department of Biotechnology (DBT), potentially paving the way for partnerships between researchers and industry players interested in these innovative applications.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Spatial OMICS Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Spatial OMICS Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Spatial OMICS Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Akoya Biosciences, Inc., Bio-Techne Corporation, Biognosys AG, BioSpyder Technologies Inc., Brooks Automation, Inc., Bruker Corporation, Danaher Corporation, Dovetail Genomics, LLC by Cantata Bio, LLC, Hologic, Inc., IonPath, Inc., Lunaphore Technologies S.A., Molecular Machines & Industries GmbH, NanoString Technologies, Inc., PerkinElmer, Inc., RareCyte, Inc., Rebus Biosystems, Inc., Resolve BioSciences GmbH, S2 Genomics, Inc., Seven Bridges Genomics Inc, Standard BioTools Inc., Ultivue, Inc., Veranome Biosystems, LLC by Applied Materials, Inc., and Vizgen, Inc..

Market Segmentation & Coverage

This research report categorizes the Spatial OMICS Market to forecast the revenues and analyze trends in each of the following sub-markets:

Technology
- Genomics
- Proteomics
- Transcriptomics

Sample Type
- FFPE
- Fresh Frozen

Product
- Consumables
- Instruments
  - Flow Cytometry
  - IHC
  - Mass Spectrometry
  - Microscopy
  - Sequencing Platforms

Software
- Bioinformatics Tools
- Imaging Tools
- Storage & Management Databases

Workflow
- Data Analysis
- Instrumental Analysis
- Sample Preparation

End-use
- Academic & Translational Research Institutes
- Pharmaceutical and Biotechnology Companies

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Spatial OMICS Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Spatial OMICS Market?

3. What are the technology trends and regulatory frameworks in the Spatial OMICS Market?

4. What is the market share of the leading vendors in the Spatial OMICS Market?

5. Which modes and strategic moves are suitable for entering the Spatial OMICS Market?

Product Code: MRR-3E7F10ED1A77

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rapid Advances in the Sequencing of Tissues, Genes, and Single Cell
  - 5.1.1.2. Rise in Government Support for Genomics and Sequencing Technologies
  - 5.1.1.3. Increasing Demand for Personalized Medicine
- 5.1.2. Restraints
  - 5.1.2.1. Slow Implementation of Technology
- 5.1.3. Opportunities
  - 5.1.3.1. Gradual Development of Novel Technologies for Spatial OMICS
  - 5.1.3.2. Rising Focusing on New Approaches for Increasing the Application of FFPE in Spatial Transcriptomic Studies Owing to Presence of Substantial Research Organizations
- 5.1.4. Challenges
  - 5.1.4.1. Challenges Pertaining to the Single-Cell Transcriptomics
5.2. Market Segmentation Analysis
- 5.2.1. Product: Penetration of mass spectrometry for spatial distribution of different molecules from tissue
- 5.2.2. End-use: Significant application of spatial OMICS technologies by Academic & translational research institutes for cellular mechanisms studies
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis
5.8. Client Customization

6. Spatial OMICS Market, by Technology

6.1. Introduction
6.2. Genomics
6.3. Proteomics
6.4. Transcriptomics

7. Spatial OMICS Market, by Sample Type

7.1. Introduction
7.2. FFPE
7.3. Fresh Frozen

8. Spatial OMICS Market, by Product

8.1. Introduction
8.2. Consumables
8.3. Instruments
8.4. Software

9. Spatial OMICS Market, by Workflow

9.1. Introduction
9.2. Data Analysis
9.3. Instrumental Analysis
9.4. Sample Preparation

10. Spatial OMICS Market, by End-use

10.1. Introduction
10.2. Academic & Translational Research Institutes
10.3. Pharmaceutical and Biotechnology Companies

11. Americas Spatial OMICS Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Spatial OMICS Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Spatial OMICS Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
- 14.3.1. OMAPiX Announces Strategic Partnerships with Spatial Biology Platform Providers to Accelerate Life Science Research and Drug Development
- 14.3.2. Owkin Invests USD 50m In Spatial Omics Project That Revolutionizes Cancer Research
- 14.3.3. Bio-Techne And Lunaphore Establish Strategic Partnership To Develop The First Fully Automated Same-Slide Spatial Multiomics Solution

15. Competitive Portfolio

15.1. Key Company Profiles
15.2. Key Product Portfolio